Autism researchers worldwide could use the mouse model to study ways to compensate for the gene and improve symptoms in people with autism spectrum disorders and Phelan-McDermid Syndrome
Gene duplication has been proposed as playing a key role in innovation since the 1970s, but latest findings add important empirical evidence to support this theory
The gene therapy treatment was designed to slow or stop sight loss, however, two of the patients experienced a significant improvement in vision that was sustained for at least four years